Amanote Research
Register
Sign In
Do Long-Acting Β2-Adrenoceptor Agonists Enhance the Anti-Inflammatory Effect of Glucocorticoids in Asthma?
European Respiratory Journal
- United Kingdom
doi 10.1183/09031936.01.00092301
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Pulmonary
Respiratory Medicine
Date
June 1, 2001
Authors
A.J. Knox
Y.M. Zhu
L. Pang
Publisher
European Respiratory Society (ERS)
Related search
Potential Masking Effect on Dyspnoea Perception by Short- And Long-Acting Β2-Agonists in Asthma
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Adipokine Resistin Predicts Anti-Inflammatory Effect of Glucocorticoids in Asthma
Journal of Inflammation
Clinical Biochemistry
Cell Biology
Interactions of Glucocorticoids and Β2-Agonists
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Long-Acting 2-Agonists in Asthma: Safety Concerns
CMAJ
Medicine
Unaltered Perception of Dyspnoea During Treatment With Long-Acting Β2-Agonists
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Effect of Short- And Long-Acting Inhaled Β2-Agonists on Exhaled Nitric Oxide in Asthmatic Patients
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Inhaled Long-Acting Β2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis
PLoS ONE
Multidisciplinary
The Debate About the Use of Long-Acting Inhaled ß-Agonists in Asthma
Barcelona Respiratory Network
The Debate About the Use of Long-Acting Inhaled ß-Agonists in Asthma
Barcelona Respiratory Network